720 related articles for article (PubMed ID: 14606082)
21. Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.
Flisiak R; Jaroszewicz J; Lapinski TW; Flisiak I; Prokopowiczi D
World J Gastroenterol; 2005 Nov; 11(43):6833-8. PubMed ID: 16425392
[TBL] [Abstract][Full Text] [Related]
22. Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis.
Walsh KM; Timms P; Campbell S; MacSween RN; Morris AJ
Dig Dis Sci; 1999 Mar; 44(3):624-30. PubMed ID: 10080160
[TBL] [Abstract][Full Text] [Related]
23. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis.
Zheng M; Cai WM; Weng HL; Liu RH
World J Gastroenterol; 2002 Dec; 8(6):1073-6. PubMed ID: 12439928
[TBL] [Abstract][Full Text] [Related]
24. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors.
Yang C; Zeisberg M; Mosterman B; Sudhakar A; Yerramalla U; Holthaus K; Xu L; Eng F; Afdhal N; Kalluri R
Gastroenterology; 2003 Jan; 124(1):147-59. PubMed ID: 12512039
[TBL] [Abstract][Full Text] [Related]
25. [The relationship between TGFbeta1 and TIMP-1 and its effects on the diagnosis of hepatic fibrosis].
Zhang LF; Tian XX; Wang CF
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):258-60. PubMed ID: 17456311
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of tissue inhibitor of metalloproteinase-1 are correlated with liver fibrosis in patients with chronic hepatitis B.
Zhu CL; Li WT; Li Y; Gao RT
J Dig Dis; 2012 Nov; 13(11):558-63. PubMed ID: 23107442
[TBL] [Abstract][Full Text] [Related]
27. Platelet-derived growth factor-D modulates extracellular matrix homeostasis and remodeling through TIMP-1 induction and attenuation of MMP-2 and MMP-9 gelatinase activities.
Borkham-Kamphorst E; Alexi P; Tihaa L; Haas U; Weiskirchen R
Biochem Biophys Res Commun; 2015 Feb; 457(3):307-13. PubMed ID: 25576870
[TBL] [Abstract][Full Text] [Related]
28. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
29. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
[TBL] [Abstract][Full Text] [Related]
31. Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cells.
Zhang LJ; Chen YX; Chen ZX; Huang YH; Yu JP; Wang XZ
World J Gastroenterol; 2004 Sep; 10(17):2574-9. PubMed ID: 15300910
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase, tissue inhibitor of metalloproteinase and transforming growth factor-beta 1 in frozen shoulder, and their changes as response to intensive stretching and supervised neglect exercise.
Lubis AM; Lubis VK
J Orthop Sci; 2013 Jul; 18(4):519-27. PubMed ID: 23604641
[TBL] [Abstract][Full Text] [Related]
33. Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C.
Lichtinghagen R; Huegel O; Seifert T; Haberkorn CI; Michels D; Flemming P; Bahr M; Boeker KH
Clin Chem; 2000 Feb; 46(2):183-92. PubMed ID: 10657374
[TBL] [Abstract][Full Text] [Related]
34. TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB.
Risinger GM; Updike DL; Bullen EC; Tomasek JJ; Howard EW
Am J Physiol Cell Physiol; 2010 Jan; 298(1):C191-201. PubMed ID: 19846754
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
36. Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants.
Lefeuvre C; Roux M; Blanchard S; Le Guillou-Guillemette H; Boursier J; Lunel-Fabiani F; Jeannin P; Pivert A; Ducancelle A
Sci Rep; 2022 Jun; 12(1):10261. PubMed ID: 35715541
[TBL] [Abstract][Full Text] [Related]
37. [Transforming growth factor-β1 small interfering RNA regulates platelet-derived growth factor and phosphorylated extracellular regulated protein kinase in rats with hepatic fibrosis: an experimental study].
Zhou XF; Jiang YJ; Zhang Y; Sun H; Liu Q; Shi XF
Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):701-705. PubMed ID: 29108193
[No Abstract] [Full Text] [Related]
38. Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients.
Larrousse M; Laguno M; Segarra M; De Lazzari E; Martinez E; Blanco JL; León A; Deulofeu R; Miquel R; Milinkovic A; Lonca M; Miró JM; Biglia A; Murillas J; Gatell JM; Mallolas J
J Acquir Immune Defic Syndr; 2007 Nov; 46(3):304-11. PubMed ID: 18172937
[TBL] [Abstract][Full Text] [Related]
39. Activation of p38 MAPK suppresses matrix metalloproteinase-1 gene expression induced by platelet-derived growth factor.
Endo H; Utani A; Shinkai H
Arch Dermatol Res; 2003 Mar; 294(12):552-8. PubMed ID: 12624781
[TBL] [Abstract][Full Text] [Related]
40. [Effect of Gandou Decoction IV combined with short-term decoppering therapy with sodium dimercapto-sulphonate on serum indexes of hepatic fibrosis in patients with Wilson' s disease].
Xue BC; Yang RM; Hu JY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Sep; 27(9):785-8. PubMed ID: 17969887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
